Other Capital Market Information | 13 May 2019 18:53
Fresenius Medical Care AG & Co. KGaA / Announcement pursuant to Art. 5 para.
1 lit. b), para. 3 of Regulation (EU) No 596/2014 and Art. 2 para. 3 of
Delegated Regulation (EU) 2016/1052
13.05.2019 / 18:53
Dissemination of a Post-admission Duties announcement transmitted by DGAP -
a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.
---------------------------------------------------------------------------
- Share buy-back - 9th Interim and Final Report
In the period from May 06, 2019 until and including May 10, 2019, a total
of 97,510 shares were repurchased within the framework of the share buy-
back programme of Fresenius Medical Care AG & Co. KGaA ('Fresenius Medical
Care') announced on March 11, 2019 pursuant to Art. 5 para. 1 lit. a) of
Regulation (EU) No 596/2014 and Art. 2 para. 1 of Delegated Regulation (EU)
2016/1052.
The purchase was carried out exclusively by a credit institution
commissioned by Fresenius Medical Care via the XETRA trading platform on
the Frankfurt Stock Exchange:
Day of repurchase Aggregated volume in Weighted average share
number of shares price
in EUR
06.05.2019 15,000 74.4874
07.05.2019 15,000 73.9889
08.05.2019 50,000 73.7934
10.05.2019 17,510 73.0246
The total volume of shares repurchased within the framework of this share
buy-back in the period from March 12, 2019 until and including May 10, 2019
therefore amounts to 3,770,772 shares. The weighted average share price
paid for these shares amounted to EUR 72.3084. This concludes the share
buy-back programme.
Detailed information on the transactions pursuant to Art. 2 para. 3 of
Delegated Regulation (EU) 2016/1052 is available on Fresenius Medical
Care's website at www.freseniusmedicalcare.com under section Investors.
Fresenius Medical Care AG & Co. KGaA
represented by Fresenius Medical Care Management AG
represented by its Management Board
Bad Homburg v.d.H., May 13, 2019
---------------------------------------------------------------------------
13.05.2019 The DGAP Distribution Services include Regulatory Announcements,
Financial/Corporate News and Press Releases.
Archive at www.dgap.de
---------------------------------------------------------------------------
Language: English
Company: Fresenius Medical Care AG & Co. KGaA
Else-Kröner-Straße 1
61352 Bad Homburg
Germany
Internet: www.freseniusmedicalcare.com
End of News DGAP News Service